Becton Dickinson's BD Diagnostics gets FDA clearance for its BD ProbeTec

|By:, SA News Editor

Becton, Dickinson (BDX -1.7%) subsidiary BD Diagnostics says the FDA has approved their BD ProbeTec Trichomonas vaginalis Amplified DNA Assay for use with the BD Viper System with XTR Technology.

The DNA assay is used for the detection of T. vaginalis DNA in endocervical and vaginal samples as well as neat urine specimens to aid in the diagnosis of trichomoniasis.